Susan Wolf
University of North Carolina, Chapel Hill
Health care is transitioning from genetics to genomics, in which single-gene testing for diagnosis is being replaced by multi-gene panels, genome-wide sequencing, and other multi-genic tests for disease diagnosis, prediction, prognosis, and treatment. This health care transition is spurring a new set of increased or novel liability risks for health care providers and test laboratories. This article describes this transition in both medical care and liability, and addresses 11 areas of potential increased or novel liability risk, offering recommendations to both health care and legal actors to address and manage those liability risks.
Keywords No keywords specified (fix it)
Categories (categorize this paper)
DOI 10.1177/1073110520916994
Edit this record
Mark as duplicate
Export citation
Find it on Scholar
Request removal from index
Revision history

Download options

PhilArchive copy

Upload a copy of this paper     Check publisher's policy     Papers currently archived: 69,114
External links

Setup an account with your affiliations in order to access resources via your University's proxy server
Configure custom proxy (use this if your affiliation does not provide a proxy)
Through your library

References found in this work BETA

View all 15 references / Add more references

Citations of this work BETA

The Streetlight Effect: Regulating Genomics Where the Light Is.Barbara J. Evans - 2020 - Journal of Law, Medicine and Ethics 48 (1):105-118.

Add more citations

Similar books and articles

Impact of Cost Containment Measures on Medical Liability.S. Callens, I. Volbragt & H. Nys - 2006 - Journal of Evaluation in Clinical Practice 12 (6):595-600.


Added to PP index

Total views
4 ( #1,273,919 of 2,499,060 )

Recent downloads (6 months)
1 ( #419,059 of 2,499,060 )

How can I increase my downloads?


My notes